c-Met+ Cytotoxic T Lymphocytes Exhibit Enhanced Cytotoxicity in Mice and Humans In Vitro Tumor Models

Mahdia Benkhoucha1, Ngoc Lan Tran1, Isis Senoner1

  • 1Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland.

Biomedicines
|December 23, 2023
PubMed
Summary

Hepatocyte growth factor (HGF) receptor c-Met positive cytotoxic T lymphocytes (CTLs) show enhanced anti-tumor immunity. Targeting the HGF/c-Met pathway may improve CTL-based cancer immunotherapies.